| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1080/01926230701618516
A Critical Comparison of Murine Pathology and Epidemiological Data of TCDD, PCB126, and PeCDF
1 Toxicologic Pathology, Drug Safety Research Laboratories, Astellas Pharma Inc., Yodogawa, Osaka 532-8514, Japan Correspondence: Address correspondence to Abraham Nyska, Toxicological Pathologist, Haharuv 18, P.O. Box 184, Timrat, 23840, Israel. E-mail:anyska{at}bezeqint.net 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, or dioxin) and dioxin-like compounds (DLCs) induce numerous toxicities, including developmental, endocrine, immunological, and multi-organ carcinogenic, in animals and/or humans. Multiple studies completed by the National Toxicology Program (NTP) focused on the effects caused in Harlan Sprague-Dawley rats by specific DLCs, among them the prototypical dioxin, TCDD. Because humans are exposed daily to a combination of DLCs, primarily via ingestion of food, the Toxic Equivalency Factor (TEF) was developed in order to evaluate health hazards caused by these mixtures. Herein we review the pathological effects reported in humans exposed to TCDD; 3,3',4,4',5-pentachlorobiphenyl (PCB 126); and 2,3,4,7,8,-pentachlorodibenzofuran (PeCDF) and compare them to similar changes seen in NTP murine studies performed with the same compounds. While there were differences in specific pathologies observed, clear consistency in the target organs affected (liver, oral cavity, cardiovascular system, immune system, thyroid, pancreas, and lung) could be seen in both human studies and rodent toxicity and carcinogenicity investigations.
Key Words: Carcinogenesis dioxin human PCB126 PeCDF rodent TCDD Abbreviations: AhR, aryl hydrocarbon receptor ATSDR, Agency for Toxic Substances and Disease Registry CYP, cytochrome P450 DLC, dioxin-like compound IARC, International Agency for Research on Cancer NTP, National Toxicology Program PCB 126, 3, 3', 4, 4'5-pentachlorobiphenyl PCDD, polychlorinated dibenzodioxin PCDF, polychlorinated dibenzofuran PeCDF, 2, 3, 4, 7, 8-pentachlorodibenzofuran TCDD, 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin TBG, thyroxine-binding globulin UGT, UDP-glucuronosyltransferases
|